GTC Biotherapeutics (fka GTCB)

[DragonBits]

I agree, a RS makes the most sense, GTC could raise up to 5-10 times more cash after a RS than before.

If the RS gets turned down, then GTC might issue some of the remaining 74 million shares at ~.44, most likely along with warrants, and probaby at a lower price than 0.44 given the history on past deals.

LFB will probably ensure GTC survives, but LFB would extract a very high cost from GTC to do that.

And this wouldn't be much of a selling point for GTC and any future partners. Keep us alive or we cut off your supply of drug and doom your investment, great selling point.

IMO not a lot of pleasant choices for GTC, but I agree, the turmoil might well create a better buying point.